Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SANUWAVE Health (SNWV) Shares Outstanding (Weighted Average) (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 91.88% to $8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.6 million through Dec 2025, up 91.88% year-over-year, with the annual reading at $8.6 million for FY2025, 91.88% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $8.6 million at SANUWAVE Health, roughly flat from $8.6 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $683.8 million in Q3 2023, with the low at $3.1 million in Q1 2024.
  • Average Shares Outstanding (Weighted Average) over 3 years is $157.5 million, with a median of $8.6 million recorded in 2025.
  • The sharpest move saw Shares Outstanding (Weighted Average) plummeted 99.53% in 2024, then surged 175.79% in 2025.
  • Over 3 years, Shares Outstanding (Weighted Average) stood at $3.6 million in 2023, then grew by 24.18% to $4.5 million in 2024, then soared by 91.88% to $8.6 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $8.6 million, $8.6 million, and $8.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.